Breast Cancer Prevention: Where Are We?

被引：2
|
作者：
Nangia, Julie R. [1 ]
Rimawi, Mothaffar F. [1 ]
机构：
[1] Baylor Coll Med, Dal L Duncan Comprehens Canc Ctr, 7200 Cambridge,7th Floor, Houston, TX 77030 USA
来源：
JCO ONCOLOGY PRACTICE | 2021年 / 17卷 / 12期
关键词：
RISK; MORTALITY; FOLATE; WOMEN; OBESITY; INDEX;
D O I：
10.1200/OP.21.00605
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：720 / 722
页数：3
相关论文
共 50 条
  • [41] Prevention of type 1 diabetes: where we are and where we are going
    Frontino, Giulio
    Guercio, Nuzio S.
    Scaramuzza, Andrea
    D'Annunzio, Giuseppe
    Toni, Sonia
    Citriniti, Felice
    Bonfanti, Riccardo
    MINERVA PEDIATRICS, 2021, 73 (06): : 486 - 503
  • [42] HIV prevention 2010: where are we now and where are we going?
    Cohen, Myron S.
    Fidler, Sarah
    CURRENT OPINION IN HIV AND AIDS, 2010, 5 (04) : 265 - 268
  • [43] miRNA - Therapeutic tool in breast cancer? Where are we now?
    Zaleska, Karolina
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2015, 20 (02) : 79 - 86
  • [44] DIETARY-FAT AND BREAST-CANCER - WHERE ARE WE
    WHITTEMORE, AS
    HENDERSON, BE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (10) : 762 - 763
  • [45] Molecular targeted therapies in breast cancer: Where are we now?
    Widakowich, Christian
    de Azambuja, Evandro
    Gil, Thierry
    Cardoso, Fatima
    Dinh, Phuong
    Awada, Ahmad
    Piccart-Gebhart, Martine
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (7-8): : 1375 - 1387
  • [46] Integrating PARP inhibitors into the management of breast cancer: where are we?
    Azim, Hamdy A.
    Kassem, Loay
    Azim, Hatem, Jr.
    CHINESE CLINICAL ONCOLOGY, 2021, 10 (05)
  • [47] Small is beautiful: microRNAs and breast cancer - where are we now?
    Verghese, E. T.
    Hanby, A. M.
    Speirs, V.
    Hughes, T. A.
    JOURNAL OF PATHOLOGY, 2008, 215 (03): : 214 - 221
  • [48] DIETARY-FAT AND BREAST-CANCER - WHERE WE ARE
    FREEDMAN, LS
    PRENTICE, RL
    CLIFFORD, C
    HARLAN, W
    HENDERSON, M
    ROSSOUW, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (10) : 764 - 765
  • [49] Adjuvant chemotherapy in elderly patients with breast cancer: where are we?
    Wildiers, H
    Brain, EGC
    CURRENT OPINION IN ONCOLOGY, 2005, 17 (06) : 566 - 572
  • [50] Role of endocrine therapy in breast cancer - where are we going?
    Lonning, PE
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 18 (01) : VII - IX
12345